ALung Technologies continues to invest in the research and development of advanced respiratory technologies including specialty membranes, coatings and device designs which will someday result in even smaller, simpler, and safer respiratory support products.

ALung also maintains a strong relationship with the University of Pittsburgh’s McGowan Institute for Regenerative Medicine (MIRM) from which the Hemolung technology originated.

Dr. Federspiel continues to develop new technologies in his Medical Devices Laboratory which have the potential to further revolutionize the field of extracorporeal lung support.